Pay in 4 interest-free payments of $6.73 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
GLP-1 Timeline: From Diabetes to Pediatric Weight Management 2005: First GLP-1 medications approved for Type 2 diabetes in adults 2014: FDA approves Saxenda (liraglutide) as the first GLP-1 for weight loss 2022: Wegovy approved for adolescents 12 and older 2023: American Academy of Pediatrics endorses GLP-1s for pediatric obesity 2025: FDA considering approval for children as young as 6 years old Though the FDA approved Saxenda as the first GLP-1 for weight loss back in 2014, it wasnt until the last few years that the popularity and availability of these medications for obesity have skyrocketed
Sell H, Blher M, Klting N, et al
Cn Omega 9 thng c tm thy trong cc loi ht, du, qu hch v rau
The drug is given through weekly self-injections
US$ 27.41
US$ 20.77
US$ 28.83
